Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-11

FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for fluvoxamine maleate (Endo USA, Inc.).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluvoxamine (fluvoxamine)

Snippet

SUPPL AP for FLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE)